Literature DB >> 15714252

NMDA receptor involvement in the effects of low dose domoic acid in neonatal rats.

R A R Tasker1, M A Perry, T A Doucette, C L Ryan.   

Abstract

We have previously reported that neonatal rats display enhanced sensitivity to domoic acid relative to adults, and that perinatal injections of low doses of domoic acid alter early associational learning in the newborn rat. The current study was designed to further investigate the effects of low dose domoic acid on neonatal odour conditioning and to determine if the observed effects are due in part to an action on NMDA receptors. Groups of rat pups were conditioned to a novel odour on postnatal day (PND) 8, injected with 20 microg/kg domoic acid either alone, or in combination with the NMDA antagonist CPP (or appropriate controls), daily from day 8-14, re-exposed to the conditioning odour or a novel odour on day 9, and tested for odour preference on day 13 using a standard 3-choice paradigm. Results indicated that rats treated with domoic acid spent significantly more time over the conditioning odour than did saline-treated rats when tested on PND 13. This effect was antagonized by concomitant injection of CPP, indicating an involvement of NMDA receptors in the actions of DOM in this paradigm. Rats injected with either saline or CPP alone showed the opposite effect, i.e. a preference for the alternate odour. The results indicate that a very low dose of DOM produces a conditioned odour preference in neonatal rats and that this effect is due in part to NMDA receptor involvement, thereby emphasizing a role for both kainate and NMDA glutamate receptors in implicit memory.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15714252     DOI: 10.1007/s00726-005-0167-z

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  8 in total

Review 1.  Domoic acid as a developmental neurotoxin.

Authors:  Lucio G Costa; Gennaro Giordano; Elaine M Faustman
Journal:  Neurotoxicology       Date:  2010-05-13       Impact factor: 4.294

2.  Progressive changes in hippocampal cytoarchitecture in a neurodevelopmental rat model of epilepsy: implications for understanding presymptomatic epileptogenesis, predictive diagnosis, and targeted treatments.

Authors:  Paul B Bernard; Leslie A Ramsay; Debra S MacDonald; R Andrew Tasker
Journal:  EPMA J       Date:  2017-08-29       Impact factor: 6.543

Review 3.  Neurological disease rises from ocean to bring model for human epilepsy to life.

Authors:  John S Ramsdell
Journal:  Toxins (Basel)       Date:  2010-06-28       Impact factor: 4.546

Review 4.  Neurotoxic Agent-Induced Injury in Neurodegenerative Disease Model: Focus on Involvement of Glutamate Receptors.

Authors:  Md Jakaria; Shin-Young Park; Md Ezazul Haque; Govindarajan Karthivashan; In-Su Kim; Palanivel Ganesan; Dong-Kug Choi
Journal:  Front Mol Neurosci       Date:  2018-08-29       Impact factor: 5.639

Review 5.  Public health risks associated with chronic, low-level domoic acid exposure: A review of the evidence.

Authors:  Rebekah Petroff; Alicia Hendrix; Sara Shum; Kimberly S Grant; Kathi A Lefebvre; Thomas M Burbacher
Journal:  Pharmacol Ther       Date:  2021-04-28       Impact factor: 12.310

Review 6.  Domoic acid toxicologic pathology: a review.

Authors:  Olga M Pulido
Journal:  Mar Drugs       Date:  2008-05-28       Impact factor: 5.118

7.  Proteomic Analysis of Plasma from California Sea Lions (Zalophus californianus) Reveals Apolipoprotein E as a Candidate Biomarker of Chronic Domoic Acid Toxicosis.

Authors:  Benjamin A Neely; Jason A Ferrante; J Mauro Chaves; Jennifer L Soper; Jonas S Almeida; John M Arthur; Frances M D Gulland; Michael G Janech
Journal:  PLoS One       Date:  2015-04-28       Impact factor: 3.240

8.  Developmental Neurotoxicity of the Harmful Algal Bloom Toxin Domoic Acid: Cellular and Molecular Mechanisms Underlying Altered Behavior in the Zebrafish Model.

Authors:  Jennifer M Panlilio; Neelakanteswar Aluru; Mark E Hahn
Journal:  Environ Health Perspect       Date:  2020-11-04       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.